Evidence map›Paper›PMID 39540115›Full record

ArticleJournal of clinical and translational science2024

Lessons learned from COVID-19 to overcome challenges in conducting outpatient clinical trials to find safe and effective therapeutics for the next infectious pandemic.

Minn A Oh, Judith Currier, Akram Khan, Eleftherios Mylonakis, Matthew Newell, Rachel Bender Ignacio, Nick Jilg, Basmah Safdar, Lisa H Merck, Davey M Smith

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical and translational science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Minn A OhDepartment of Medicine, Oregon Health & Science University, Portland, OR, USA.ORCID https://orcid.org/0009-0008-3727-9611
Judith CurrierDepartment of Medicine, University of California, Los Angeles, CA, USA.
Akram KhanDepartment of Medicine, Oregon Health & Science University, Portland, OR, USA.ORCID https://orcid.org/0000-0003-3091-632X
Eleftherios MylonakisDepartment of Medicine, Houston Methodist Hospital, Houston, TX, USA.
Matthew NewellGlobal Health and Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Rachel Bender IgnacioDepartment of Medicine, University of Washington, Seattle, WA, USA.
Nick JilgDepartment of Medicine, Harvard Medical School, Massachusetts General Hospital, Brigham and Women's Hospital, Boston, MA, USA.
Basmah SafdarDepartment of Emergency Medicine, Yale University, New Haven, CT, USA.
Lisa H MerckDepartment of Energy Medicine, Virginia Commonwealth, Richmond, VA, USA.
Davey M SmithAltman Clinical and Translational Research Institute, University of California, San Diego, CA, USA.ORCID https://orcid.org/0000-0003-3603-1733

Funding

Determining the component causes of systemic immune activation that moderate HIV acquisition and establishment of the latent viral reservoirK23AI129659 · NIAID · UNIVERSITY OF WASHINGTON · PI BENDER IGNACIO, RACHEL ANN · 2017 to 2021
$868k
NIAID NIH HHS K23 AI129659
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39540115
PMCPMC11557272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.